While aspartame's low-calorie structure provides an advantage for metabolic diseases such as obesity and diabetes, its potential effects on insulin sensitivity and gut microbiota have led to different conclusions. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.